Related references
Note: Only part of the references are listed.The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer
Amikar Sehdev et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2015)
Metformin for Primary Colorectal Cancer Prevention in Patients With Diabetes: A Case-Control Study in a US Population
Amikar Sehdev et al.
CANCER (2015)
Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
C. R. Garrett et al.
BRITISH JOURNAL OF CANCER (2012)
p70S6 kinase phosphorylation for pharmacodynamic monitoring
B. Hartmann
CLINICA CHIMICA ACTA (2012)
Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients
Ezra E. W. Cohen et al.
CLINICAL CANCER RESEARCH (2012)
Rapalogs in viral cancers
Dirk P. Dittmer et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Autophagy modulation as a potential therapeutic target for diverse diseases
David C. Rubinsztein et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Metformin and neoplasia: Implications and indications
Ahmad Aljada et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
Ramandeep Rattan et al.
JOURNAL OF ONCOLOGY (2012)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
Seth A. Wander et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
Anne T. Nies et al.
PLOS ONE (2011)
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
Mahvash Zakikhani et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
Michael Pollak
CANCER PREVENTION RESEARCH (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
PHARMACODYNAMIC EVALUATION OF TEMSIROLIMUS IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED-STAGE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Oleksandr Ekshyyan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises
Timothy A. Yap et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: A phase I tumor pharmacodynamic study in patients with advanced solid tumors
Josep Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors
Anne O'Donnell et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells
A Boulay et al.
CANCER RESEARCH (2004)
From beach to bedside: History of the development of sirolimus
KL Napoli et al.
THERAPEUTIC DRUG MONITORING (2001)
Share Paper
